Value of the lung immune prognostic index in patients with advanced small cell lung cancer treated with programmed death-ligand 1 and programmed death-1 inhibitors in the Chinese alpine region

PurposeTo assess the potential added value of the lung immune prognostic index (LIPI) in patients with small cell lung cancer (SCLC), treated with programmed death-ligand 1 (PD-L1)/programmed death-1 (PD-1) inhibitors, who lived in the Chinese alpine region.Methods120 SCLC patients treated with PD-L...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Meiling Zhang, Jingwei Hao, Yunjiao Wu, Ziyi Gao, Meng Wang
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2024-09-01
Serija:	Frontiers in Oncology
Teme:	lung immune prognostic index (LIPI) small cell lung cancer (SCLC) programmed death-ligand 1 (PD-L1) programmed death-1 (PD-1) immune-related adverse events (irAEs) prognostic factor
Online dostop:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1411548/full
Oznake:	Označite Brez oznak, prvi označite!